Cancer Drug News Halaven® (eribulin) listed on the Pharmaceutical Benefits Scheme for patients with previously treated, advanced liposarcoma December 6, 2017 Australian patients suffering from advanced liposarcoma, previously treated with chemotherapy, will now have access to…